vs
Side-by-side financial comparison of BRC Inc. (BRCC) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $112.7M, roughly 1.5× BRC Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 6.5%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 7.0%).
BRC Inc., operating under the Black Rifle Coffee brand, is a U.S.-headquartered premium coffee and lifestyle brand. It sells roasted coffee beans, ready-to-drink coffee products, branded apparel, and outdoor gear, targeting primarily veteran, first responder, and outdoor enthusiast consumer segments across North America, via both e-commerce and physical retail channels.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
BRCC vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $112.7M | $168.4M |
| Net Profit | $-3.2M | — |
| Gross Margin | 32.1% | — |
| Operating Margin | -6.3% | 50.6% |
| Net Margin | -2.8% | — |
| Revenue YoY | 6.5% | 143.7% |
| Net Profit YoY | -29.3% | — |
| EPS (diluted) | $-0.02 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $112.7M | $168.4M | ||
| Q3 25 | $100.7M | $87.3M | ||
| Q2 25 | $94.8M | $82.4M | ||
| Q1 25 | $90.0M | $65.0M | ||
| Q4 24 | $105.9M | $69.1M | ||
| Q3 24 | $98.2M | $51.6M | ||
| Q2 24 | $89.0M | $73.8M | ||
| Q1 24 | $98.4M | $137.7M |
| Q4 25 | $-3.2M | — | ||
| Q3 25 | $-486.0K | $-31.3M | ||
| Q2 25 | $-5.3M | $-12.7M | ||
| Q1 25 | $-2.9M | $-40.5M | ||
| Q4 24 | $-2.5M | — | ||
| Q3 24 | $-535.0K | $-29.5M | ||
| Q2 24 | $-482.0K | $-61.9M | ||
| Q1 24 | $548.0K | $61.0M |
| Q4 25 | 32.1% | — | ||
| Q3 25 | 36.9% | — | ||
| Q2 25 | 33.9% | — | ||
| Q1 25 | 36.1% | — | ||
| Q4 24 | 38.1% | — | ||
| Q3 24 | 42.1% | — | ||
| Q2 24 | 41.9% | — | ||
| Q1 24 | 42.9% | — |
| Q4 25 | -6.3% | 50.6% | ||
| Q3 25 | 0.5% | -11.4% | ||
| Q2 25 | -13.3% | 8.6% | ||
| Q1 25 | -6.0% | -34.0% | ||
| Q4 24 | -2.1% | -6.4% | ||
| Q3 24 | 1.1% | -31.0% | ||
| Q2 24 | 1.1% | 3.5% | ||
| Q1 24 | 4.0% | 52.5% |
| Q4 25 | -2.8% | — | ||
| Q3 25 | -0.5% | -35.9% | ||
| Q2 25 | -5.6% | -15.4% | ||
| Q1 25 | -3.2% | -62.2% | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | -0.5% | -57.2% | ||
| Q2 24 | -0.5% | -83.9% | ||
| Q1 24 | 0.6% | 44.3% |
| Q4 25 | $-0.02 | $0.32 | ||
| Q3 25 | $0.00 | $-0.16 | ||
| Q2 25 | $-0.07 | $-0.06 | ||
| Q1 25 | $-0.04 | $-0.21 | ||
| Q4 24 | $-0.03 | $-0.14 | ||
| Q3 24 | $-0.01 | $-0.15 | ||
| Q2 24 | $-0.01 | $-0.33 | ||
| Q1 24 | $0.01 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.3M | $167.9M |
| Total DebtLower is stronger | $34.7M | — |
| Stockholders' EquityBook value | $45.7M | $-302.0M |
| Total Assets | $209.2M | $465.9M |
| Debt / EquityLower = less leverage | 0.76× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.3M | $167.9M | ||
| Q3 25 | $9.5M | $92.4M | ||
| Q2 25 | $4.3M | $86.1M | ||
| Q1 25 | $3.9M | $114.6M | ||
| Q4 24 | $6.8M | $144.8M | ||
| Q3 24 | $7.3M | $144.7M | ||
| Q2 24 | $9.6M | $189.3M | ||
| Q1 24 | $4.0M | $226.6M |
| Q4 25 | $34.7M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $72.7M | — | ||
| Q1 25 | $68.8M | — | ||
| Q4 24 | $65.1M | — | ||
| Q3 24 | $64.9M | — | ||
| Q2 24 | $66.5M | — | ||
| Q1 24 | $61.5M | — |
| Q4 25 | $45.7M | $-302.0M | ||
| Q3 25 | $48.0M | $-451.4M | ||
| Q2 25 | $10.1M | $-433.5M | ||
| Q1 25 | $11.2M | $-426.2M | ||
| Q4 24 | $13.2M | $-388.7M | ||
| Q3 24 | $14.5M | $-370.2M | ||
| Q2 24 | $14.9M | $-344.2M | ||
| Q1 24 | $14.6M | $-294.3M |
| Q4 25 | $209.2M | $465.9M | ||
| Q3 25 | $222.4M | $364.0M | ||
| Q2 25 | $225.3M | $347.1M | ||
| Q1 25 | $222.9M | $324.0M | ||
| Q4 24 | $227.4M | $343.8M | ||
| Q3 24 | $233.7M | $314.1M | ||
| Q2 24 | $229.9M | $352.3M | ||
| Q1 24 | $227.2M | $373.1M |
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 7.19× | — | ||
| Q1 25 | 6.15× | — | ||
| Q4 24 | 4.94× | — | ||
| Q3 24 | 4.47× | — | ||
| Q2 24 | 4.46× | — | ||
| Q1 24 | 4.21× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.7M | $45.2M |
| Free Cash FlowOCF − Capex | $-9.4M | — |
| FCF MarginFCF / Revenue | -8.3% | — |
| Capex IntensityCapex / Revenue | 0.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.7M | $45.2M | ||
| Q3 25 | $6.4M | $-4.3M | ||
| Q2 25 | $-3.3M | $-31.4M | ||
| Q1 25 | $-4.1M | $-22.6M | ||
| Q4 24 | $2.2M | $-35.0M | ||
| Q3 24 | $1.9M | $-35.3M | ||
| Q2 24 | $2.3M | $-7.2M | ||
| Q1 24 | $4.9M | $53.8M |
| Q4 25 | $-9.4M | — | ||
| Q3 25 | $5.6M | — | ||
| Q2 25 | $-4.3M | — | ||
| Q1 25 | $-5.3M | — | ||
| Q4 24 | $504.0K | — | ||
| Q3 24 | $-205.0K | $-35.5M | ||
| Q2 24 | $147.0K | $-7.3M | ||
| Q1 24 | $2.2M | $53.8M |
| Q4 25 | -8.3% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | -4.5% | — | ||
| Q1 25 | -5.9% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | -0.2% | -68.7% | ||
| Q2 24 | 0.2% | -9.9% | ||
| Q1 24 | 2.2% | 39.0% |
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 1.3% | 0.0% | ||
| Q4 24 | 1.6% | 0.0% | ||
| Q3 24 | 2.2% | 0.3% | ||
| Q2 24 | 2.4% | 0.1% | ||
| Q1 24 | 2.8% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 8.97× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRCC
| Sales Channel Through Intermediary | $72.9M | 65% |
| Sales Channel Directly To Consumer | $34.4M | 31% |
| Outpost | $5.4M | 5% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
